Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C - Clinical and virologic implications

Rolland C. Dickson, Masashi Mizokami, Etsuro Orito, Ke Ping Qian, Johnson Y.N. Lau

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Background. Monitoring hepatitis C viremia may be useful in the management of liver transplant patients with recurrent hepatitis C virus (HCV) infection. The clinical utility of a newly described fluorescent enzyme immunoassay for the detection of serum HCV core antigen was evaluated. Methods. Serum samples prospectively collected from 57/63 consecutive patients transplanted for HCV-related end-stage liver disease were assayed for both serum HCV core antigen by fluorescent enzyme immunoassay and HCV RNA level using a branched chain DNA signal amplification assay. HCV genotype was determined by restriction fragment length polymorphism analysis based on 5' untranslated region. One-and 2-year annual protocol liver biopsies from these patients were graded for inflammation, fibrosis, and cholestasis. Results. Serum HCV core antigen and HCV RNA were detected in a similar proportion of samples (256/281 vs. 260/281, P=NS), and there was an excellent correlation between assays (r2=0.905, P<0.0001) independent of HCV genotype. A conversion equation between HCV core antigen and HCV RNA was constructed to estimate the HCV core antigen to RNA ratio to be around 231 to 1. Mean serum HCV core antigen levels peaked initially at 3 months posttransplant but there was significant interpatient variation as to when peak levels occurred. A high serum HCV core antigen level in the first 6 months was associated with histological deterioration in terms of bridging fibrosis, cirrhosis, severe cholestasis, or retransplantation by 2-year follow-up. Conclusion. Determination of serum HCV core antigen level reflects HCV viremia and may have clinical implications in liver transplant patients with HCV recurrence.

Original languageEnglish (US)
Pages (from-to)1512-1516
Number of pages5
JournalTransplantation
Volume68
Issue number10
DOIs
StatePublished - Nov 27 1999

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C - Clinical and virologic implications'. Together they form a unique fingerprint.

Cite this